Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Agios appoints Novartis vet Biller as CSO

September 21, 2010 11:35 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Agios Pharmaceuticals Inc., a Cambridge biotech focused on cancer metabolism-based therapeutics, has named Novartis veteran Scott Biller as chief scientific officer.

Holy Redeemer Partners with MobileMD to Deliver Health Information Exchange Services to Care Community

September 21, 2010 11:34 am | by Bio-Medicine.Org | News | Comments

WARMINSTER and HUNTINGDON VALLEY, Pa., Sept. 21 /- MobileMD, Warminster, and Holy Redeemer Health System, Huntingdon Valley, announced today an agreement to provide state-of-the-art Health Information Exchange (HIE) services to Holy Redeemer and its entire healthcare provider community....

TOPICS:

Introduction of New Products and Increased Uptake of Innovative Materials to Drive US Bone Graft Substitute Market to Nearly $2.3 Billion by 2015

September 21, 2010 11:34 am | by Bio-Medicine.Org | News | Comments

TORONTO, Sept. 21 /- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the introduction and adoption of new growth factors, combined with greater variety and improved features of newer products, will drive the US bone graft...

TOPICS:
Advertisement

New Global Survey Reveals Over One in Three Patients Fail to Take Insulin as Prescribed

September 21, 2010 11:32 am | by Bio-Medicine.Org | News | Comments

STOCKHOLM, Sept. 21 /- More than one in three diabetes patients skip doses or fail to take their insulin as prescribed, stating that they have done so on average three times in the last month, and 77 percent of physicians estimate that in reality this number could be as high as six...

TOPICS:

ImmunoGen begins clinical tests of cancer treatment

September 21, 2010 11:32 am | by Mass High Tech: The Journal of New England Technology | News | Comments

ImmunoGen Inc. has begun clinical testing of its drug candidate SAR566658, co-developed with Paris pharmaceutical giant Sanofi-aventis, in treating ovarian, breast, cervical, lung and pancreatic cancers.

TOPICS:

The AACR to Host Molecular Diagnostics Conference

September 21, 2010 11:32 am | by AACR | News | Comments

DENVER — The American Association for Cancer Research will host its Fourth AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development from Sept. 27-30, 2010, at the Sheraton Denver Downtown in Denver, Colo.

TOPICS:

Four Tips to Avoid Molding Mishaps

September 21, 2010 11:09 am | by Brian Hayes | Articles | Comments

Design engineers can sometimes get so caught up with the technical specifications of a molding project that they overlook the non-technical processes and miss out on an opportunity to improve production throughput. This article lays out four tips that the design engineer should follow when taking part in their next molding project so as to get the most out of the project.

TSX-listed corporate dividends and distributions declared Sept. 21, 2010

September 21, 2010 10:45 am | by The Associated Press | News | Comments

Dividends or distributions were declared or updated on the followed listed issues on the Toronto Stock Exchange on September 21, 2010.Claymore Canadian Fundamental Index Etf Units (TSX:CRQ): $0.06. Payable Jul 07. Record Jun 29.Claymore Bric Etf Units (TSX:CBQ): $0.035. Payable Jul 07. Record...

Advertisement

Solos Endoscopy, Inc. to Hold Annual Shareholder Meeting September 28, 2010

September 21, 2010 10:32 am | by Bio-Medicine.Org | News | Comments

BOSTON, Sept. 21 /- Solos Endoscopy, Inc. (Pink Sheets: SNDY ) is pleased to announce that the Company will be holding its annual shareholder meeting on Tuesday, September 28, 2010 at 9:00am EDT. The meeting will be held at the Hilton of Boston/Dedham located at 25 Allied Drive, Dedham,...

TOPICS:

Sophisticated Disposables

September 21, 2010 10:29 am | by David Fink and Andre LaFreniere | Articles | Comments

A growing number of medical device disposable products are looking more like traditional sophisticated reusable instruments. There are a number of trends, both technical and non-technical, that are driving this prevailing change. This article looks to briefly discuss some of those trends and their influence on the emergence of smarter, more functional disposables.

Connections at the Heart of the Matter

September 21, 2010 10:03 am | by Mark D. Halloran | Articles | Comments

Ensuring proper connection of leads into implantable cardiac devices can be challenging, especially for small start-ups whose specialty may not focus on this area. As a result, one company is offering a solution that can be completely integrated easily into a device to help satisfy the requirements of this component and enable a faster time to market.

TOPICS:

Boston Scientific stent gains extended approval

September 21, 2010 9:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Boston Scientific Corp. today announced that one of its coronary stents, the Promus Element Everolimus-Eluting Coronary Stent System, has been approved for additional treatments of diabetes and heart attacks in the European economic community.

National Health Education Campaign: "When Will You Pick?"™ Encourages Families to Make Flu Vaccination a Priority This Fall

September 21, 2010 9:32 am | by Bio-Medicine.Org | News | Comments

GAITHERSBURG, Md., Sept. 21 /- New school schedules, exciting sporting events, and daily homework assignments are already keeping families busy this fall. But how many have taken time to get their annual flu vaccinations? The U.S. Centers for Disease Control and Prevention (CDC) advises...

TOPICS:

Pittsburgh Life Sciences Greenhouse Executive-in-Residence Launches Medical Device Company

September 21, 2010 9:32 am | by Bio-Medicine.Org | News | Comments

PITTSBURGH, Sept. 21 /- The Pittsburgh Life Sciences Greenhouse (PLSG), the organization providing capital investments and customized company formation and business growth programs to western Pennsylvania's life sciences enterprises, announced today that one of its nationally recognized...

TOPICS:

Class I Medical Device Recall: Symbiq One and Two-Channel Infusers

September 21, 2010 8:32 am | by U.S. Food & Drug Administration | News | Comments

Reason for Recall: There is potential for unrestricted flow of fluid or medication if the administration set (cassette) is removed before the cassette carriage fully opens and the slide/roller clamp is not closed. Additionally, when unrestricted flow...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading